To evaluate if TPM improves the functional and structural outcome, visual function is planned at 40 weeks gestational age, 4 ½, 12, 18 and 24 months corrected age.
To evaluate if propranolol improves the functional and structural outcome, visual function and ophthalmologic examination are planned at 40 weeks gestational age, 1, 4 122, 18, 18 and 24 months corrected age.
Outcome measures include visual outcomes, complications, visual function and quality of life measurements.
Outcomes: visual acuity, visual function, refractive outcomes, complications including endothelial cell loss and cost-effectiveness.
Indeed, supplementation of infant formula with LC-PUFA appears to be associated with a beneficial effect on short-term neurodevelopmental outcome and visual function [ 25- 27].
To investigate the risk factors that influence outcome of visual function in children with glaucoma.
When breastfeeding is not possible, supplementation of infant formula with long chain polyunsaturated fatty acids appears to promote neurodevelopmental outcome and visual function.
Recently, there is a growing recognition of the importance of patient-reported outcomes of visual functioning.
Patient-reported outcomes related to visual function are important as, ultimately, the clinical relevance of measures of visual function, structure, and electrophysiology will be determined by how they relate to or predict measures of vision-specific quality of life.
Numerous studies have found positive correlations between blood DHA levels and improvements in cognitive or visual function outcomes of breastfed and formula-fed infants.
